Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Gynecol Oncol. 2016 Jul 14;143(1):46–53. doi: 10.1016/j.ygyno.2016.07.090

Table 2c.

Comparison of concordance statistics (with 95% confidence intervals) for each ProMisE molecular subgroups.

Average MMR-D POLE EDM p53 wt p53 abn
Sensitivity 0.9 0.94 (0.72-1) 0.82 (0.52-0.95) 0.84 (0.62-0.94) 1 (0.74-1)
Specificity 0.96 0.93 (0.81-0.97) 0.98 (0.89-1) 0.97 (0.87-1) 0.98 (0.89-1)
Pos Pred Value 0.9 0.83 (0.61-0.94) 0.9 (0.6-0.99) 0.94 (0.73-1) 0.92 (0.65-1)
Neg Pred Value 0.96 0.97 (0.87-1) 0.96 (0.86-0.99) 0.92 (0.8-0.97) 1 (0.92-1)
Prevalence 0.28 (0.18-0.41) 0.19 (0.11-0.31) 0.33 (0.22-0.46) 0.19 (0.11-0.31)
Detection Rate 0.26 (0.17-0.39) 0.16 (0.09-0.27) 0.28 (0.18-0.41) 0.19 (0.11-0.31)
Detection Prev 0.32 (0.21-0.44) 0.18 (0.1-0.29) 0.3 (0.2-0.43) 0.21 (0.12-0.33)
Accuracy 0.95 0.93 (0.83-0.97) 0.95 (0.86-0.98) 0.93 (0.83-0.97) 0.98 (0.91-1)
Balanced Acc 0.93 0.93 0.9 0.91 0.99